Program Description

Despite medical advancements in drugs and delivery devices for asthma and allergy sufferers, some patients are not getting appropriate dosages. But new advances are being worked on that could improve care for many through nanotechnology. Rob Neville, executive chairman of Savara Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the use of nanotechnology as an emerging way to administer drugs more effectively for improved respiratory care.

Series

Focus on Allergy

Guest

Hosted by